iNFixion team attends Children’s Tumor Foundation Global NF Conference in Brussels

Members of iNFixion’s executive team headed to Brussels for the 2024 Global NF Conference, the leading international meeting shaping the future of neurofibromatosis and schwannomatosis research and clinical care. Organized by the Children’s Tumor Foundation and the European NF Group, this event brought together over 1,000 experts, clinicians, researchers, and advocates. The team was honored to reconnect with the global NF community, share insights, and contribute to the progress driving new treatments forward. Several new collaboration opportunities were identified, including potential projects with the amazing NF1 research team from Murdoch Children’s Research Institute in Melbourne, Australia.